Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

LC-TQ Mass Spectrometers

By Drug Discovery Trends Editor | September 12, 2012

Bruker has launched two LC-triple quadrupole (LC-TQ) mass spectrometers, the high-performance EVOQ Qube and the ultra-high sensitivity EVOQ Elite, which are setting standards for analytical performance and quantitative robustness. As with Bruker’s SCION GC-TQ platform, the EVOQ series delivers major advances in robustness, ease of method developments, and productivity.

The EVOQ LC-TQ systems incorporate Bruker’s Advance ultra-high pressure liquid chromatography (UHPLC) systems. In addition, the EVOQ platform features several major innovations:
• The industry’s first vacuum-insulated probe (VIP) heated electrospray technology preserves and ionizes thermally fragile molecules with outstanding sensitivity.
• The Active Exhaust atmospheric pressure ionization source with a robust orifice vacuum interface significantly enhances quantitative robustness for difficult samples.  
• The ‘flat-tuning’ Interlaced Quadrupole Dual Funnel (IQ-DF) maximizes sensitivity.
• PACER software enables ‘exception based data-review’, a revolutionary feature that significantly reduces the error rate for quantitative analysis.

Bruker’s lens-free triple-quad mass filter design, which enhances MRM performance, is standard on all EVOQ systems, making the EVOQ LC-TQ inherently easier to use and maintain. Other high-performance TQ features include Bruker’s unique Compound Based Scanning (CBS) technology, the novel VIP heated-ESI and APCI ion sources, fast 14,000 amu/sec scan speed and 25 milliseconds positive/negative ion switching, all for leading-edge TQ performance and analytical power.

Bruker


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE